GeneDx Holdings Corp - Class A (WGS) Company Profile & Statistics

GeneDx Holdings Corp - Class A
WGS
(Nasdaq - US)
Closed
72.00
+2.62 (+3.78%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
69.99
High
75.38
Low
69.99

About GeneDx Holdings Corp - Class A

CEO

Katherine Stueland

Headquarters

333 ludlow street, north tower, 6th floor

stamford, ct 06902, united states

Auditor

Ernst & Young LLP

Employees

1,000

Share Holders

Website

www.genedx.com

Industry

medical or nursing services

Sector

health services

Company Overview

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

GeneDx Holdings Corp - Class A Statistics

Valuation Measures

Market Capitalization ²	1.88B
Enterprise Value	1.87B
Enterprise Value/EBITDA (ttm)	-53.28
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	9.54
Price to Sales (ttm)	7.30
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	59.16%
Operating Margin (ttm)	-10.41%
Profit Margin (ttm)	-32.37%
Return on Equity (ttm)	-13.35%
Return on Invested Capital (ttm)	-32.07%
Return on Assets (ttm)	-6.91%

Income Statement

Revenue (ttm)	267.23M
Revenue Per Share (ttm)	9.73
Gross Profit (ttm)	158.95M
EBITDA (ttm)³	-35.17M
Net Income Avi to Common (ttm)	-83.50M
Diluted EPS (ttm)	-3.11

Share Statistics

Beta (5Y Monthly)	2.11
52-Week Change	5079.86%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	27.47M
Dividend Yield	0.00%
Float ⁴	19.97M
% Held by Insiders	27.30%
% Held by Institutions	61.72%

Balance Sheet

Total Cash (mrq)	116.46M
Total Cash Per Share (mrq)	4.24
Total Debt (mrq)	52.03M
Total Debt/Equity (mrq)	25.44%
Current Ratio (mrq)	2.40%
Quick Ratio (mrq)	2.27%
Book Value Per Share (mrq)	7.45

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.93
Free Cash Flow (ytd)	-27.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GeneDx Holdings Corp - Class A

Trade With A Regulated Broker